Clinical and translational results from the phase II ABACO trial evaluating the activity of cabozantinib in pretreated patients with metastatic colorectal cancer.

De Falco V, Vitiello PP, Ciardiello D, Grasso G, Mariella E, Martini G, Napolitano S, Cardone C, Arrichiello G, Varriale E, Di Bisceglie M, Latiano T, Maiello E, Reginelli A, Brunese MC, Cappabianca S, Del Tufo S, Orlando A, Nicastro A, Caraglia F, Esposito L, Renato D, Avallone A, Orditura M, Fazio N, Curigliano G, Zampino MG, Bardelli A, Ciardiello F, Troiani T, Martinelli E

Open source

DOI: 10.1016/j.esmogo.2026.100303
Published: 2026 Mar
Container: ESMO gastrointestinal oncology
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.esmogo.2026.100303,
  title = {Clinical and translational results from the phase II ABACO trial evaluating the activity of cabozantinib in pretreated patients with metastatic colorectal cancer.},
  author = {De Falco V and Vitiello PP and Ciardiello D and Grasso G and Mariella E and Martini G and Napolitano S and Cardone C and Arrichiello G and Varriale E and Di Bisceglie M and Latiano T and Maiello E and Reginelli A and Brunese MC and Cappabianca S and Del Tufo S and Orlando A and Nicastro A and Caraglia F and Esposito L and Renato D and Avallone A and Orditura M and Fazio N and Curigliano G and Zampino MG and Bardelli A and Ciardiello F and Troiani T and Martinelli E},
  year = {2026},
  journal = {ESMO gastrointestinal oncology},
  doi = {10.1016/j.esmogo.2026.100303},
  url = {https://doi.org/10.1016/j.esmogo.2026.100303}
}

RIS

TY  - JOUR
TI  - Clinical and translational results from the phase II ABACO trial evaluating the activity of cabozantinib in pretreated patients with metastatic colorectal cancer.
AU  - De Falco V
AU  - Vitiello PP
AU  - Ciardiello D
AU  - Grasso G
AU  - Mariella E
AU  - Martini G
AU  - Napolitano S
AU  - Cardone C
AU  - Arrichiello G
AU  - Varriale E
AU  - Di Bisceglie M
AU  - Latiano T
AU  - Maiello E
AU  - Reginelli A
AU  - Brunese MC
AU  - Cappabianca S
AU  - Del Tufo S
AU  - Orlando A
AU  - Nicastro A
AU  - Caraglia F
AU  - Esposito L
AU  - Renato D
AU  - Avallone A
AU  - Orditura M
AU  - Fazio N
AU  - Curigliano G
AU  - Zampino MG
AU  - Bardelli A
AU  - Ciardiello F
AU  - Troiani T
AU  - Martinelli E
PY  - 2026
JO  - ESMO gastrointestinal oncology
DO  - 10.1016/j.esmogo.2026.100303
UR  - https://doi.org/10.1016/j.esmogo.2026.100303
ER  -

APA

V, D. F., PP, V., D, C., G, G., E, M., G, M., S, N., C, C., G, A., E, V., M, D. B., T, L., E, M., A, R., MC, B., S, C., S, D. T., A, O., A, N., F, C., L, E., D, R., A, A., M, O., N, F., G, C., MG, Z., A, B., F, C., T, T., & E, M. (2026). Clinical and translational results from the phase II ABACO trial evaluating the activity of cabozantinib in pretreated patients with metastatic colorectal cancer.. ESMO gastrointestinal oncology. https://doi.org/10.1016/j.esmogo.2026.100303

Source records

pubmed · retrieved 2026-09-25T21:46:31.080Z
doaj · retrieved 2026-09-25T21:46:31.098Z